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Introduction {#S0001}
============

Gastrointestinal sign and symptoms are common in diabetes mellitus and usually attributed to autonomic neuropathy ([@CIT0001]--[@CIT0005]). Studies suggest that GI symptoms affect quality of life adversely ([@CIT0006]--[@CIT0010]) and represent a substantial cause of morbidity in patients with diabetes ([@CIT0003]), the available epidemiological data relating to the prevalence of GI symptoms in diabetes is conflicting and can be challenged on methodological grounds ([@CIT0002], [@CIT0011]).

Schvarcz et al. ([@CIT0012]) evaluated the prevalence of GI symptoms in a non-selected, population-based cohort of 110 young adult patients with long-standing type 1 diabetes mellitus, compared with age- and sex-matched control subjects. In the patients with diabetes, there was an increased prevalence of upper GI symptoms, such as anorexia and vomiting, whereas there was no difference in the frequency of symptoms referable to the lower GI tract. The prevalence of GI symptoms was significantly greater in women than in men and in those subjects with the worst glycemic control, as assessed by glycated hemoglobin concentrations. Janatuinen et al. ([@CIT0013]) found that the prevalence of upper GI symptoms including abdominal pain, constipation, and diarrhea was similar in patients with diabetes and controls. In that study, only middle-aged patients with type 1 or type 2 diabetes mellitus who were treated with insulin or oral hypoglycemic drugs were evaluated, and the questionnaire used to evaluate symptoms was not a validated measure. Finally, a recent community-based study from the United States ([@CIT0013]) failed to detect differences in prevalence rates for GI tract symptoms in persons with or without diabetes mellitus, except for a lower prevalence of heartburn and an increased prevalence of constipation or laxative use in residents with type 1 diabetes mellitus. The findings, however, were surprising as the study did not report a single subject with diarrhea. Furthermore the controls for type 1 diabetes mellitus reported more constipation compared with the older group of controls for persons with type 2 diabetes. Furthermore, the authors reported no differences in peripheral neuropathy and minor differences in autonomic neuropathy between subjects with type 1diabetes and age-matched controls.

We devised an epidemiological survey using a questionnaire, and we hypothesized that troublesome GI symptoms would be more prevalent in patients with diabetes compared with community controls, after adjusting for age and sex. Furthermore, we hypothesized that GI symptoms would be associated with poor glycemic control.

Patients and Methods {#S0002}
====================

This descriptive, cross- sectional, referral- based study was conducted during 2003 in Tabriz, Iran. Among the diabetic patients who had been referred to a metabolic clinic, 200 patients were selected randomly. A questionnaire has been designed including age, sex, past medical history, GI symptoms and signs, type of diabetes mellitus, duration and complications of diabetes mellitus. Studied patients were interviewed by specialists and underwent a physical examination.

Results are expressed as mean ± standard deviation (SD). Comparisons between means were carried out using the Student\'s unpaired and paired t test. The chi-square and Fisher exact tests were used to comparison categorical variables. P \< 0.05 was considered statistically significant. The study project was endorsed by the ethics committee of Department of Endoscopy Sina University, Tabriz University of Medical Sciences, Iran.

Results {#S0003}
=======

Of the 200 subjects interviewed, ninety one percent of patients had type II diabetes. Thirty three percent of studied patients had appropriate control on their hyperglycemia and 67% of patients had poor controlled diabetes (40.2% were male). The prevalence of complications of diabetes reported in our diabetic patients were 74% (30% were male). 61.5% of studied patients had neuropathy, 38.5% had retinopathy and also neuropathy. There were no evidences of nephropathy in any patients. Forty two diabetic patients had the history of hypertension, 26 persons had the history of hyperlipidemia and 61 parsons had hypertension and also hyper lipidemia. Neuropathies in complicated diabetic patients were reported in 23.8% compared with 19.2% in diabetic without any other complications.

GI symptoms and signs were reported in 92% of patients and 40% of them were male. The most common symptoms were constipation followed by bloating, mass protruding through anus, abdominal pain, and dyspepsia ([Table 1](#T0001){ref-type="table"}). Seventy two percent of diabetic patients who had constipation also had complications of diabetes. Sixty three percent of them had poor controlled diabetes and 74.1% had diabetes for more than 5 years. The most frequently observed sign was abdominal tenderness on deep palpation ([Table 2](#T0002){ref-type="table"}). GI symptoms prevalence in different age groups was as follow: 71.4% in aged 20-29 years, 77.7% in 30-39 years, 82.3% in 40-49 years, 93.3% in 50-59 years, 97.2% in 60-69 years, and 100% in 70-79 years. Diarrhea, with symptoms lasting more than 2 weeks, was reported in 3% of patients.

###### 

Frequency of gastrointestinal symptoms in patients with diabetes mellitus, Tabriz, Iran

                                  Abdominal Pain                         dyspepsia   diarrhea   constipation   bloating   heartburn   melena   hematochezia   Mass protruding Through anus
  ------------------------------- -------------------------------------- ----------- ---------- -------------- ---------- ----------- -------- -------------- ------------------------------
  Sex                                                                                                                                                         
   Male                           17                                     23          2          51             37         15          9        10             36
   Female                         54                                     37          4          68             51         36          8        7              29
  Type of Diabetes Mellitus                                                                                                                                   
   Type I                         8                                      4           1          0              6          3           0        2              0
   Type II                        54                                     54          5          119            82         48          17       15             65
   P-value                        NS[\*](#TF0001){ref-type="table-fn"}   NS          NS         NS             NS         NS          NS       NS             NS
  Complication                                                                                                                                                
   Yes                            51                                     50          6          13             71         45          12       15             56
   No                             11                                     10          0          106            17         6           4        2              9
   P-value                        0.001                                  0.001       0.001      0.01           0.007      NS          NS       0.012          0.006
  Glycemia control                                                                                                                                            
   Yes                            15                                     18          2          35             30         9           1        2              14
   No                             47                                     47          4          84             58         42          16       15             51
   P-value                        NS                                     NS          0.021      0.001          NS         NS          NS       NS             0.012
  Duration of Diabetes Mellitus                                                                                                                               
   Under 5 years                  32                                     27          4          39             36         21          11       6              25
   5-10 years                     17                                     15          0          37             29         14          2        5              16
   More than 10 years             13                                     18          2          43             23         16          4        6              22
   P-value                        NS                                     NS          NS         0.014          NS         NS          NS       NS             NS

NS: Not Significant

###### 

Frequency of gastrointestinal signs in patients with diabetes mellitus, Tabriz, Iran

                                  Hepatomegaly                           Splenomegaly   Epigastric tenderness   Abdominal hernia   Icterus   Tenderness on deep palpation
  ------------------------------- -------------------------------------- -------------- ----------------------- ------------------ --------- ------------------------------
  Sex                                                                                                                                        
   Male                           5                                      1              7                       6                  2         31
   Female                         7                                      4              31                      8                  2         77
  Type of Diabetes Mellitus                                                                                                                  
   Type I                         0                                      0              0                       2                  0         6
   Type II                        12                                     5              38                      12                 4         102
   P-value                        NS[\*](#TF0002){ref-type="table-fn"}   NS             NS                      NS                 NS        NS
  Complication                                                                                                                               
   Yes                            10                                     3              38                      11                 2         21
   No                             2                                      2              0                       3                  2         87
   P-value                        NS                                     NS             NS                      NS                 NS        NS
  Glycemia control                                                                                                                           
   Yes                            4                                      2              10                      10                 2         31
   No                             8                                      3              28                      4                  2         77
   P-value                        NS                                     NS             NS                      0.003              0.009     NS
  Duration of Diabetes Mellitus                                                                                                              
   Under 5 years                  4                                      1              12                      8                  2         48
   5-10 years                     6                                      1              11                      4                  2         32
   More than 10 years             2                                      3              15                      2                  0         28
   P-value                        NS                                     NS             NS                      NS                 NS        NS

NS: Not Significant

Discussion {#S0004}
==========

Prevalence rates of GI symptoms and signs in studied population increased with age, 97.2% of subjects in the 60-69 year age group. In our previous study on this age group constipation was the most common symptom, 29.1% in diabetic patients with complications and 18.1% in diabetic patients without complications ([@CIT0014]). In the current study there is a relationship between constipation, poor controlled diabetes (62.7%), duration of diabetes (74.1%) and the complication of diabetes (71.6%).

Diarrhea lasting longer than 2 weeks had been reported in 3% patients, in comparison with a much lower prevalence in the general population (0.4%) ([@CIT0014]). Another study reported diarrheal symptoms had a prevalence of 3% in complicated diabetic patients and 1.9% in non complicated diabetic patient ([@CIT0015]). This study also reported a relationship between diarrhea more than 2 weeks and uncontrolled diabetes mellitus (p= 0.001).

The prevalence of heartburn in our study was 25.5%, but this prevalence was 3% in general population. Reflux in our previous study reported 8.3% in diabetic patients without any complications and 18.9% in complicated diabetic patients, and 11.6% in patients with DMI and 22.9% in control group, and 19.8% in patients with DM II ([@CIT0014]) and 24.3% ([@CIT0015]) in control group and these results were similar to our study. In our study constipation, melaena and mass protruding anus have not been reported in DM I. There was no relationship between type of diabetes and abdominal pain, dyspepsia, diarrhea more than 2 weeks, bloating, and heartburn. Abdominal hernia had been reported in 7% of patients, in compare to general population 0.5% ([@CIT0014]). Seventy five percent of the abdominal hernias were inguinal hernia and rests were incisional, femoral and umbilical hernias. In our study most patients had incisional and umbilical hernias.

The limitation of this study is we investigated the single clinic population and no control group was recruited from a general non-diabetic population. Therefore, we suggest that further studies with matched control group may be of interest.
